Znn3bq.jpeg
²é¿´: 617  |  »Ø¸´: 0

nyl8791

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ¡¶½á¹¹»¯Ñ§¡·ÔÓÖ¾²Î¿¼ÎÄÏ×ÐÞ¸ÄÇóÖú

¡¶½á¹¹»¯Ñ§¡·ÔÓÖ¾²Î¿¼ÎÄÏ×ÐÞ¸ÄÇóÖú£¬Ö÷±à˵¸ñʽ²»¶Ô£¬ÎÒÒѾ­Ð£¶Ô¹ýÁË£¬µ«Ã»·¢ÏÖÎÊÌ⣬¸ßÊÖ¿ÉÒÔ°ïÎÒ¿´ÏÂÂð£¿Ð»Ð»£¡
Fr¨ªas-Gonz¨¢lez, S. E.; Angeles-Anguiano, E.; Mendoza-Herrera, A.; Escutia-Calzada, D.; Ordaz-Pichardo, C. Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(II) complex against human cervical cancer. Toxicology. 2013, 314, 155¨C165.
Florea, A. M.; B¨¹sselberg, D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers. 2011, 3, 1351¨C1371.
Gielen, M.; Tiekink (Eds.), E. R. T. Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine. New York: Wiley, 2005, P 1¨C17.
Devereux, M.; O¡¯Shea, D.; O¡¯Connor, M.; Grehan, H. Synthesis, catalase, superoxide dismutase and antitumour activities of copper(II) carboxylate complexes incorporating benzimidazole, 1,10-phenanthroline and bipyridine ligands: X-ray crystal structures of [Cu(BZA)2(bipy)(H2O)], [Cu(SalH)2(BZDH)2] and [Cu(CH3COO)2(5,6-DMBZDH)2] (SalH2 = salicylic acid; BZAH = benzoic acid; BZDH = benzimidazole and 5,6-DMBZDH = 5,6-dimethylbenzimidazole). Polyhedron. 2007, 26, 4073¨C4084.
McCann, M.; Coyle, B.; McKay, S.; McCormack, P.; Kavanagh, K.; Devereux, M.; McKee, V.; Kinsela, P.; Connor, R. O.; Clynes, M. Synthesis and X-ray crystal structure of [Ag(phendio)2]ClO4 (phendio = 1,10-phenanthroline-5,6-dione) and its effects on fungal and mammalian cells. Biometals. 2004, 17, 635¨C654.
Huang, R. L.; Wallqvist, A.; Covell, D. G. Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. Biochemical Pharmacology. 2005, 69, 1009¨C1039.
Wu, H. L.; Yuan, J. K.; Bai, Y.; Wang, H.; Pan, G. L.; Kong, J. A seven-coordinated manganese(II) complex with V-shaped ligand bis(N-benzylbenzimidazol-2-ylmethyl)benzylamine: Synthesis, structure, DNA-binding properties and antioxidant activities. J. Photoch. Photobio. B. 2012, 116, 13¨C21.
Wu, H. L.; Yuan, J. K.; Pan, G. L. The V-shaped ligand bis(N-allylbenzimidazol-2-ylmethyl)benzylamine and its Ag(I) complex: Synthesis, crystal structure, DNA-binding properties and antioxidation. J. Photoch. Photobio. B. 2013, 122, 37¨C 44.
Kaniskan, N.; Ogretir, C. Investigation of acid¨Cbase behaviour of some 2-pyridylbenzimidazoles using semi-empirical methods. J. Mol. Struct. 2002, 584, 45¨C52.
Sączewski, F.; Dziemidowicz-Borys, E.; Bednarski, P. J. Synthesis, crystal structure and biological activities of copper(II) Complexes with chelating bidentate 2-substituted benzimidazole ligands. Journal of Inorganic Biochemistry. 2006, 100, 1389 ¨C1398.
Rowan, R.; Moran, C.; McCann, M.; Kavanagh, K. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. BioMetals. 2009, 22, 461¨C 467.
McCann, M.; Geraghty, M.; Devereux, M.; O¡¯Shea, D.; Mason., J.; O¡¯Sullivan, L. Insights Into the Mode of Action of the Anti-Candida Activity of 1,10-Phenanthroline and its Metal Chelates. Metal-Based Drugs. 2000, 7, 185¨C193.
Deegan, C.; Coyle, B.; McCann, M.; Devereux, M.; Egan, D. In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2¡¤4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines. Chem. Biol. Interact. 2006, 164, 115¨C125.
Cerchiaro, G.; Aquilano, K.; Filomeni, G. Isatin-Schiff base copper(II) complexes and their influence on cellular viability. Journal of Inorganic Biochemistry. 2005, 99, 1433-1440.
Puszy¨½ska-Tuszkanow, M.; Grabowski, T.; Daszkiewicz, M. Silver(I) complexes with hydantoins and allantoin ¡î: Synthesis, crystal and molecular structure, cytotoxicity and pharmacokinetics. Journal of Inorganic Biochemistry. 2011, 105, 17¨C22.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÖÇÄÜ»úÆ÷ÈË

Robot (super robot)

ÎÒÃǶ¼°®Ð¡Ä¾³æ

ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~

¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ nyl8791 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ҩѧÇóµ÷¼Á +11 RussHu 2026-04-12 13/650 2026-04-15 19:07 by zhuwenxu
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬ÉúÎïѧ326Çóµ÷¼Á +7 Áõīī 2026-04-15 7/350 2026-04-15 18:51 by ¸¡ÔÆ166
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á +9 Ö½ÉÈzhishan 2026-04-13 9/450 2026-04-15 18:28 by ANÁ÷800
[¿¼ÑÐ] ²ÄÁÏ299ר˶Çóµ÷¼Á +17 +21 2026-04-09 17/850 2026-04-15 17:20 by zs92450
[¿¼ÑÐ] 296Çóµ÷¼Á +5 Íô£¡£¿£¡ 2026-04-08 5/250 2026-04-15 14:38 by ºÚ¿Æ¼¼»¨¸ÚÑÒ
[¿¼ÑÐ] 22408 312Çóµ÷¼Á +18 ÃÅ·ÃþÃþ 2026-04-14 19/950 2026-04-15 14:23 by °ÍÈûÂÞÄÇ2015
[¿¼ÑÐ] µ÷¼ÁÇóÊÕÁô +34 ¹ûÈ»ÓÐÎÒ 2026-04-10 35/1750 2026-04-15 13:05 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +21 »ý¼«ÏòÉÏ£» 2026-04-10 23/1150 2026-04-15 12:50 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] ±¾¿Æ211£¬±¨¿¼085601-310·Ö +16 ararak 2026-04-13 16/800 2026-04-14 14:55 by Delta2012
[¿¼ÑÐ] 297Çóµ÷¼Á +23 ORCHID1 2026-04-10 26/1300 2026-04-14 13:52 by ³ÂƤƤ
[¿¼ÑÐ] 245Çóµ÷¼Á +6 ±ùÌÇéÙ?ÆûË® 2026-04-13 10/500 2026-04-14 10:49 by jyl0317
[¿¼ÑÐ] ²ÄÁÏ085601µ÷¼Á +32 ºÎÈó²É123 2026-04-10 34/1700 2026-04-14 08:47 by ľľmumu¡«
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] 280Çóµ÷¼Á +13 wzzzÍõ 2026-04-09 13/650 2026-04-12 00:31 by ÓÂÅʸ߷å0126
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ354·Ö +5 ÓêÉùÓàÉú 2026-04-11 6/300 2026-04-11 16:12 by ÓêÉùÓàÉú
[¿¼ÑÐ] 0854µ÷¼Á +4 ³¤¹­°Á 2026-04-09 4/200 2026-04-11 09:18 by Öí»á·É
[¿¼ÑÐ] ¼ª´ó¼ÆËã»ú¼¼Êõ331·Ö£¬Ó¢ÓïÁù¼¶£¬Çóµ÷¼Á +3 ·å·å021116 2026-04-09 3/150 2026-04-10 20:01 by chemisry
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧÎïÀíѧ£¬Ó¢Ò»66£¬Çóµ÷¼Á +4 ³¤ÑÌì½ì» 2026-04-08 5/250 2026-04-10 10:31 by Ó±¹û¶ù
[¿¼ÑÐ] ²ÄÁÏר˶³õÊÔ·Ö332Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬ +12 ¹ÊÈË?? 2026-04-09 12/600 2026-04-09 18:34 by Ccclqqq
[¿¼ÑÐ] Çó»úеר˶297µÚ¶þÅúµ÷¼Á +5 ʰÆâ12¡£ 2026-04-08 5/250 2026-04-09 16:43 by Ôʵ±ÊʶÈ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û